SIBN

#2568
SI-BONE, Inc. - Common Stock
18.9 6 USD
-0.01%
Market Price
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
18.91
18.97
Intervallo Annuale
11.48
21.89
Variazione giornaliera
-1.30%
Variazione Mensile
+4.93%
Variazione di 6 mesi
+22.56%
Variazione Annuale
+15.12%
Chiusura Precedente
19.2 1
Open
18.9 3
Minimo
18.9 1
Massimo
18.9 7
Volume
50
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche Documents

2026

Current report, Q3 FY2026
SI-BONE, Inc. current report, Q3 FY2026
8-K
Quarterly report, Q2 FY2026
SI-BONE, Inc. quarterly report, Q2 FY2026
10-Q
Current report, Q2 FY2026
SI-BONE, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
SI-BONE, Inc. current report, Q2 FY2026
8-K
Quarterly report, Q1 FY2026
SI-BONE, Inc. quarterly report, Q1 FY2026
10-Q
Current report, Q1 FY2026
SI-BONE, Inc. current report, Q1 FY2026
8-K
Current report, Q1 FY2026
SI-BONE, Inc. current report, Q1 FY2026
8-K

2025

Annual report, FY2025
SI-BONE, Inc. annual report, FY2025
10-K
Current report, Q4 FY2025
SI-BONE, Inc. current report, Q4 FY2025
8-K
Quarterly report, Q3 FY2025
SI-BONE, Inc. quarterly report, Q3 FY2025
10-Q

SI-BONE, Inc. current report, Q2 FY2025

Full document

SI-BONE, Inc. Form 8-K Summary

Business Context and Reporting Period

This Current Report on Form 8-K was filed by SI-BONE, Inc. on June 5, 2025, regarding the results of its Annual Meeting of Stockholders held on that date. The company is incorporated in Delaware and its common stock trades on The Nasdaq Global Market under the symbol SIBN.

Key Financial Metrics

This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on corporate governance voting results.

Material Changes and Voting Results

Approximately 89% of the company's outstanding shares (37,674,856 shares) were present or represented by proxy at the meeting. The following matters were voted upon:

  • Proposal 1 (Election of Directors): All three nominees were elected to serve until the 2028 Annual Meeting.
    • Timothy E. Davis, Jr.: 35,165,713 votes For; 1,043,089 votes Withheld.
    • Laura A. Francis: 35,477,807 votes For; 730,995 votes Withheld.
    • Jeryl L. Hilleman: 27,567,253 votes For; 8,641,549 votes Withheld.
  • Proposal 2 (Ratification of Auditors): The appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified.
    • 37,530,981 votes For; 138,292 votes Against; 5,583 votes Abstain.
  • Proposal 3 (Advisory Vote on Executive Compensation): The compensation of named executive officers was approved on an advisory basis.
    • 35,588,516 votes For; 616,661 votes Against; 3,625 votes Abstain.

Guidance, Outlook, and Risks

The filing text does not provide management commentary, financial guidance, outlook, or specific risk factors. It references a definitive proxy statement filed on April 25, 2025, for a more complete description of the matters voted upon.

Key Facts for Investor Verification

  • Verify the full text of the Proxy Statement filed on April 25, 2025, for details on director biographies and executive compensation specifics.
  • Note the significant number of votes withheld for director Jeryl L. Hilleman (8,641,549) compared to the other nominees.
  • Confirm the ratification of PricewaterhouseCoopers LLP as the auditor for the fiscal year ending December 31, 2025.
  • Review the company's upcoming financial reports for actual revenue and profitability metrics, as this 8-K contains none.

Notizie